Nifty
Sensex
:
:
11483.25
38233.41
129.00 (1.14%)
424.50 (1.12%)

Pharmaceuticals & Drugs

Rating :
61/99  (View)

BSE: 532331 | NSE: AJANTPHARM

1010.95
14.20 (1.42%)
26-Mar-2019 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  998.80
  •  1019.05
  •  998.80
  •  996.75
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  232476
  •  2350.22
  •  1457.75
  •  895.85

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 8,884.16
  • 22.63
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 8,792.87
  • N/A
  • 3.80

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.47%
  • 0.49%
  • 8.62%
  • FII
  • DII
  • Others
  • 0.37%
  • 9.16%
  • 10.89%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.79
  • 11.96
  • 7.03

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 26.04
  • 12.29
  • 2.32

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 33.83
  • 14.91
  • 4.08

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 23.04
  • 28.89
  • 25.35

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.09
  • 9.11
  • 7.74

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.09
  • 19.15
  • 18.61

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Net Sales
485.11
587.05
-17.36%
544.11
540.38
0.69%
510.99
473.12
8.00%
530.31
476.81
11.22%
Expenses
377.80
389.55
-3.02%
377.89
356.65
5.96%
353.50
345.66
2.27%
390.78
319.22
22.42%
EBITDA
107.31
197.50
-45.67%
166.22
183.73
-9.53%
157.49
127.46
23.56%
139.53
157.59
-11.46%
EBIDTM
22.12%
33.64%
30.55%
34.00%
30.82%
26.94%
26.31%
33.05%
Other Income
4.41
15.15
-70.89%
15.24
9.18
66.01%
8.13
4.76
70.80%
5.24
5.70
-8.07%
Interest
0.09
0.14
-35.71%
0.13
0.09
44.44%
0.17
0.07
142.86%
0.11
0.39
-71.79%
Depreciation
18.67
14.98
24.63%
17.49
14.55
20.21%
17.17
13.42
27.94%
16.64
18.92
-12.05%
PBT
92.96
197.53
-52.94%
163.84
178.27
-8.09%
148.28
118.73
24.89%
128.02
143.98
-11.08%
Tax
26.06
50.06
-47.94%
38.45
46.38
-17.10%
42.49
23.94
77.49%
33.53
29.96
11.92%
PAT
66.90
147.47
-54.63%
125.39
131.89
-4.93%
105.79
94.79
11.60%
94.49
114.02
-17.13%
PATM
13.79%
25.12%
23.05%
24.41%
20.70%
20.04%
17.82%
23.91%
EPS
7.56
16.67
-54.65%
14.18
14.91
-4.90%
11.96
10.72
11.57%
10.68
12.89
-17.15%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Net Sales
2,070.52
2,125.76
1,983.26
1,733.98
1,473.56
1,208.34
930.84
677.39
498.83
409.14
349.34
Net Sales Growth
-0.33%
7.19%
14.38%
17.67%
21.95%
29.81%
37.42%
35.80%
21.92%
17.12%
 
Cost Of Goods Sold
371.71
317.35
322.58
317.33
290.33
283.98
250.11
187.93
153.04
139.80
127.20
Gross Profit
1,698.81
1,808.41
1,660.68
1,416.65
1,183.23
924.36
680.73
489.46
345.80
269.35
222.14
GP Margin
82.05%
85.07%
83.73%
81.70%
80.30%
76.50%
73.13%
72.26%
69.32%
65.83%
63.59%
Total Expenditure
1,499.97
1,467.37
1,296.38
1,146.92
968.33
839.59
706.35
545.36
409.13
330.58
284.28
Power & Fuel Cost
-
27.42
18.70
15.49
12.91
11.20
10.25
7.83
6.16
4.77
3.27
% Of Sales
-
1.29%
0.94%
0.89%
0.88%
0.93%
1.10%
1.16%
1.23%
1.17%
0.94%
Employee Cost
-
376.47
295.42
256.64
200.58
156.97
123.18
93.84
70.85
45.23
40.18
% Of Sales
-
17.71%
14.90%
14.80%
13.61%
12.99%
13.23%
13.85%
14.20%
11.05%
11.50%
Manufacturing Exp.
-
215.80
192.70
174.40
130.81
96.29
81.76
60.60
40.45
31.19
11.97
% Of Sales
-
10.15%
9.72%
10.06%
8.88%
7.97%
8.78%
8.95%
8.11%
7.62%
3.43%
General & Admin Exp.
-
117.90
92.02
66.24
50.99
47.40
37.02
33.88
24.80
22.78
24.01
% Of Sales
-
5.55%
4.64%
3.82%
3.46%
3.92%
3.98%
5.00%
4.97%
5.57%
6.87%
Selling & Distn. Exp.
-
306.30
270.92
245.92
233.96
201.57
169.99
131.40
90.69
78.22
66.56
% Of Sales
-
14.41%
13.66%
14.18%
15.88%
16.68%
18.26%
19.40%
18.18%
19.12%
19.05%
Miscellaneous Exp.
-
106.13
104.04
70.90
48.75
42.18
34.04
29.88
23.15
8.60
66.56
% Of Sales
-
4.99%
5.25%
4.09%
3.31%
3.49%
3.66%
4.41%
4.64%
2.10%
3.17%
EBITDA
570.55
658.39
686.88
587.06
505.23
368.75
224.49
132.03
89.70
78.56
65.06
EBITDA Margin
27.56%
30.97%
34.63%
33.86%
34.29%
30.52%
24.12%
19.49%
17.98%
19.20%
18.62%
Other Income
33.02
24.16
23.86
21.15
16.80
13.71
5.60
6.22
9.45
1.09
2.50
Interest
0.50
0.41
1.36
4.89
5.92
8.73
19.13
15.43
18.02
20.15
23.55
Depreciation
69.97
59.59
61.21
44.43
51.64
43.88
34.17
31.87
24.75
20.73
14.20
PBT
533.10
622.55
648.17
558.89
464.47
329.85
176.79
90.95
56.39
38.76
29.81
Tax
140.53
153.91
141.34
143.28
146.15
95.97
64.68
13.69
5.67
4.76
4.38
Tax Rate
26.36%
24.72%
21.81%
25.64%
32.05%
29.10%
36.59%
15.05%
10.05%
12.28%
14.69%
PAT
392.57
468.64
506.83
415.61
309.86
233.88
112.11
77.26
50.71
34.00
25.43
PAT before Minority Interest
392.57
468.64
506.83
415.61
309.86
233.88
112.11
77.26
50.71
34.00
25.43
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
18.96%
22.05%
25.56%
23.97%
21.03%
19.36%
12.04%
11.41%
10.17%
8.31%
7.28%
PAT Growth
-19.58%
-7.54%
21.95%
34.13%
32.49%
108.62%
45.11%
52.36%
49.15%
33.70%
 
Unadjusted EPS
44.38
53.26
57.59
47.23
35.24
66.53
31.91
32.98
43.31
29.04
21.72

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Shareholder's Funds
2,041.37
1,567.69
1,190.86
841.09
593.31
393.43
298.03
228.83
184.92
157.10
Share Capital
17.69
17.69
17.69
17.68
17.67
11.80
11.80
11.80
11.80
11.80
Total Reserves
2,023.68
1,550.00
1,173.17
822.98
575.06
381.13
286.23
217.03
173.13
145.31
Non-Current Liabilities
38.56
8.90
28.63
55.67
80.62
102.46
100.59
75.64
233.23
250.78
Secured Loans
1.01
1.04
5.79
23.31
41.53
57.57
62.09
48.13
206.20
210.85
Unsecured Loans
0.00
0.00
9.08
9.94
10.77
15.76
14.00
11.42
21.77
39.37
Long Term Provisions
13.16
4.88
2.59
4.76
2.83
2.98
4.91
2.66
0.00
0.00
Current Liabilities
346.05
246.66
259.89
249.59
275.42
222.34
250.19
217.70
76.94
51.28
Trade Payables
249.63
178.18
145.57
109.06
124.54
131.71
101.32
71.19
69.25
45.48
Other Current Liabilities
63.95
46.33
56.72
58.33
47.63
19.45
43.15
29.59
0.07
0.05
Short Term Borrowings
0.00
0.00
46.25
17.90
60.55
51.26
95.27
108.71
0.00
0.00
Short Term Provisions
32.47
22.15
11.35
64.30
42.70
19.92
10.45
8.21
7.62
5.74
Total Liabilities
2,425.98
1,823.25
1,479.38
1,146.35
949.35
718.23
648.81
522.17
495.09
459.16
Net Block
1,052.66
589.17
450.74
288.09
279.39
272.56
246.12
214.03
168.46
138.27
Gross Block
1,417.23
894.94
715.73
549.85
492.00
438.49
378.01
313.15
242.58
192.49
Accumulated Depreciation
364.57
305.77
264.99
261.76
212.61
165.93
131.89
99.12
74.12
54.22
Non Current Assets
1,202.36
972.65
716.11
512.94
429.30
349.21
309.13
276.58
223.92
201.91
Capital Work in Progress
61.33
254.22
198.91
170.20
93.55
12.49
2.51
17.22
46.99
55.17
Non Current Investment
7.58
0.00
0.00
40.04
8.46
8.46
8.46
8.46
8.47
8.47
Long Term Loans & Adv.
76.79
41.88
21.29
9.34
39.15
48.61
50.75
33.54
0.00
0.00
Other Non Current Assets
4.00
2.34
4.28
5.27
8.75
7.09
1.29
3.32
0.00
0.00
Current Assets
1,223.62
850.60
763.27
633.41
520.05
369.02
339.68
245.59
271.18
257.26
Current Investments
182.38
181.56
76.78
19.46
55.00
0.00
0.00
0.00
0.00
0.00
Inventories
350.63
211.02
204.58
159.03
155.40
147.60
167.80
113.12
119.62
103.89
Sundry Debtors
492.02
323.15
372.35
258.76
202.22
150.47
141.00
103.98
96.72
100.12
Cash & Bank
93.09
69.95
43.37
136.76
60.39
46.23
11.48
11.53
14.84
8.07
Other Current Assets
105.50
8.63
6.80
11.97
47.04
24.72
19.40
16.96
39.99
45.18
Short Term Loans & Adv.
23.11
56.29
59.39
47.43
43.66
20.72
15.92
14.41
39.99
45.18
Net Current Assets
877.57
603.94
503.38
383.82
244.63
146.68
89.49
27.89
194.24
205.98
Total Assets
2,425.98
1,823.25
1,479.38
1,146.35
949.35
718.23
648.81
522.17
495.10
459.17

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Cash From Operating Activity
285.42
609.29
326.14
279.42
212.42
234.27
70.35
95.37
95.11
34.59
PBT
622.56
648.17
558.90
456.01
329.85
163.51
90.96
56.39
38.76
29.81
Adjustment
61.60
86.33
53.07
51.21
50.82
65.28
51.35
42.76
40.13
37.68
Changes in Working Capital
-259.14
25.88
-124.34
-81.69
-74.52
38.60
-54.53
5.96
21.57
-27.96
Cash after chg. in Working capital
425.02
760.38
487.63
425.53
306.15
267.39
87.78
105.11
100.46
39.54
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-139.60
-151.09
-161.49
-146.11
-93.73
-33.12
-17.43
-9.74
-5.35
-4.94
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-260.41
-383.12
-209.07
-158.36
-187.80
-103.70
-53.07
-50.71
-42.67
-81.94
Net Fixed Assets
-327.21
-235.38
-197.00
-138.00
-120.60
-68.66
-46.30
-38.81
-41.98
-80.51
Net Investments
-1.82
-104.79
-17.41
2.22
-59.98
-1.81
0.00
0.00
0.00
-0.33
Others
68.62
-42.95
5.34
-22.58
-7.22
-33.23
-6.77
-11.90
-0.69
-1.10
Cash from Financing Activity
-0.20
-201.77
-117.32
-105.19
-20.13
-104.49
-12.84
-55.89
-45.67
49.65
Net Cash Inflow / Outflow
24.81
24.40
-0.25
15.87
4.49
26.08
4.44
-11.23
6.77
2.30
Opening Cash & Equivalents
65.83
41.42
41.67
38.62
34.13
8.05
3.61
14.84
8.07
5.76
Closing Cash & Equivalent
90.64
65.82
41.42
54.49
38.62
34.13
8.05
3.61
14.84
8.07

Financial Ratios

Consolidated /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Book Value (Rs.)
231.96
178.14
135.31
95.57
67.42
44.73
33.92
26.05
21.05
17.88
ROA
22.06%
30.69%
31.66%
29.57%
28.05%
16.40%
13.20%
9.97%
7.13%
6.23%
ROE
25.97%
36.75%
40.92%
43.24%
47.47%
32.46%
29.34%
24.52%
19.89%
17.43%
ROCE
34.49%
45.74%
51.61%
56.43%
54.53%
38.62%
23.23%
17.88%
14.37%
14.91%
Fixed Asset Turnover
1.84
2.49
2.76
2.85
2.61
2.29
1.98
1.81
1.90
2.11
Receivable days
69.82
63.41
65.84
56.64
52.93
56.78
65.22
72.71
87.14
96.84
Inventory Days
48.10
37.89
37.93
38.64
45.48
61.44
74.79
84.32
98.95
101.88
Payable days
57.26
50.30
41.91
46.38
59.31
61.76
59.93
67.67
65.88
58.29
Cash Conversion Cycle
60.66
51.01
61.86
48.91
39.10
56.46
80.09
89.36
120.21
140.44
Total Debt/Equity
0.00
0.00
0.07
0.09
0.22
0.32
0.67
0.83
1.23
1.59
Interest Cover
1519.41
477.60
115.29
78.03
38.78
10.24
6.89
4.13
2.92
2.27

News Update


  • Ajanta Pharma reports 55% fall in Q3 consolidated net profit
    31st Jan 2019, 11:55 AM

    Total consolidated income of the company decreased by 18.71% at Rs 489.52 crore for Q3FY19

    Read More
  • Ajanta Pharma - Quarterly Results
    30th Jan 2019, 18:11 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.